[Construction and evaluation of a novel diagnosis pathway for 2019-Corona Virus Disease].
Z Xiong, Lei Fu, Hui Zhou, Jinkang Liu, Aiming Wang, Yan Huang, Xun Huang, Bin Yi, Jing Wu, Chunhui Li, Jun Quan, Ming Li, Yueshuang Leng, Weijun Luo, Chengping Hu, Weihua Liao
Abstract
The Xiangya pathway can predict the nucleic acid test results of COVID-19, and can be applied as a reliable strategy to screen patients with suspected COVID-19 among people aged ≥12 years in areas other than Hubei during the epidemic period of COVID-19. The cohort size needs to be increased for further validation.
Topics & Concepts
MedicineCohortEpidemiologyCohort studyInternal medicineDiseaseCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)COVID-19 Clinical Research StudiesTuberculosis Research and EpidemiologyLong-Term Effects of COVID-19